ClinicalTrials.Veeva

Menu

Effects of the Combination of L-Arabinose and Indigestible Dextrin on Obesity

H

Hiroshima University

Status

Completed

Conditions

Obesity

Treatments

Dietary Supplement: Oolong tea (Placebo)
Dietary Supplement: Oolong tea containing L-arabinose and indigestible dextrin

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT00880646
eki-124

Details and patient eligibility

About

This study aims to investigate the effect of supplement containing L-arabinose and indigestible dextrin on body mass index, body fat mass, abdominal circumference, visceral fat mass, and serum biochemical parameters in overweight subjects.

Enrollment

70 estimated patients

Sex

All

Ages

20 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Healthy as based on medical history and physical examination
  • BMI between 25 and 30 kg/m2
  • Willing not to serve as blood donor during the study
  • Informed consent signed

Exclusion criteria

  • Female subjects who are pregnant or nursing a child
  • Participation in any clinical trial up to 90 days before Day 01 of this study
  • Renal or hepatic dysfunction
  • Heart disease
  • Under medication
  • Subjects who are taking functional food designed for weight loss or serum lipid reduction

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

70 participants in 2 patient groups, including a placebo group

1
Experimental group
Treatment:
Dietary Supplement: Oolong tea containing L-arabinose and indigestible dextrin
2
Placebo Comparator group
Treatment:
Dietary Supplement: Oolong tea (Placebo)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems